Abstract:Background: New vessel formation plays a pivotal role in the pathogenesis of neovascular-related diseases. Endothelial progenitor cells (EPCs) were found to contribute to neovascular-related diseases and interference with EPC neovascularization may be a novel target for these diseases. Zoledronate (Zol) was reported to exhibit anti-angiogenic effect. Basing on these evidences, we proposed that Zol may affect EPC function to exert novel anti-angiogenic effect. In this study, we therefore investigated the effects of Zol on multiple aspects of EPC function and explored the underlying mechanisms involved.Methodology/Principal Findings: EPCs were cultured from bone marrow derived mononuclear cells. The potential effects of Zol on Angiotensin II (Ang II)-stimulated EPC proliferation, migration, adhesion, in vitro tube formation were investigated. The results showed that Ang II (1 mu M) enhanced EPC migration, adhesion, in vitro tube formation but had no effect on cell proliferation. Zol (75 and 100 mM) inhibited proliferation of EPCs and 50 mu M geranylgeranyol (GGOH) could reverse the decrease of EPC proliferation. We found for the first time that Zol (50-100 mu M) dose dependently attenuated migration, adhesion, and in vitro tube formation of EPCs stimulated by Ang II. GGOH could reverse the attenuation of EPC function induced by Zol. However, Zol did not induce EPC apoptosis. In addition, the underlying mechanisms were determined. The results revealed that Zol markedly down-regulated active RhoA stimulated by Ang II and inhibited the phosphorylation of Erk1/2 and JNK. Moreover, RhoA silencing resulted in a notable inhibition of EPC in vitro tube formation, suggesting that RhoA suppression played a pivotal role in Zol antiangiogenic effect.Conclusions/Significance: These findings suggested that Zol attenuated the promotion of EPC function stimulated by Ang II and exhibited novel antiangiogenic effect via RhoA and MAPK signaling. Thus, Zol may be served as a novel therapeutic agent for neovascular-related diseases treatment.

A-769662 Protects Osteoblasts from Hydrogen Dioxide-Induced Apoptosis Through Activating of AMP-Activated Protein Kinase (AMPK)

Simvastatin Protects Human Osteosarcoma Cells from Oxidative Stress-Induced Apoptosis Through Mitochondrial-Mediated Signaling

Targeted Activation of AMPK by GSK621 Ameliorates H2O2-induced Damages in Osteoblasts

Zoledronate Attenuates Angiogenic Effects Of Angiotensin Ii-Stimulated Endothelial Progenitor Cells Via Rhoa And Mapk Signaling

Mechanisms Underlying the Antiapoptotic and Anti-Inflammatory Effects of Monotropein in Hydrogen Peroxide-Treated Osteoblasts.

Effect Of Advanced Oxidation Protein Products On The Proliferation And Osteogenic Differentiation Of Rat Mesenchymal Stem Cells

Treatment with hydrogen molecules prevents RANKL-induced osteoclast differentiation associated with inhibition of ROS formation and inactivation of MAPK, AKT and NF-kappa B pathways in murine RAW264.7 cells

PF-06409577 Activates AMPK Signaling and Inhibits Osteosarcoma Cell Growth

Protective effects of honokiol against oxidative stress-induced apoptotic signaling in mouse podocytes treated with H2O2.

HIF-1α protects osteoblasts from ROS-induced apoptosis

Prolyl Hydroxylase Inhibitor Dimethyloxalylglycine Enhances Mesenchymal Stem Cell Survival

The specific AMPK activator A-769662 ameliorates pathological phenotypes following mitochondrial DNA depletion

The New Synthetic H2S-Releasing SDSS Protects MC3T3-E1 Osteoblasts against H2O2-Induced Apoptosis by Suppressing Oxidative Stress, Inhibiting MAPKs, and Activating the PI3K/Akt Pathway

Protective Effect of Photobiomodulation against Hydrogen Peroxide-Induced Oxidative Damage by Promoting Autophagy through Inhibition of PI3K/AKT/mTOR Pathway in MC3T3-E1 Cells

Apoptosis Repressor with Caspase Recruitment Domain Enhances Survival and Promotes Osteogenic Differentiation of Human Osteoblast Cells under Zoledronate Treatment

OSU53 Rescues Human OB-6 Osteoblastic Cells from Dexamethasone through Activating AMPK Signaling

A novel Keap1 inhibitor iKeap1 activates Nrf2 signaling and ameliorates hydrogen peroxide-induced oxidative injury and apoptosis in osteoblasts

[Advanced Oxidation Protein Products Inhibit Proliferation and Differentiation of Rat Osteoblasts Through Oxidative Stress].

GW26-e2354 R65 Ribozyme Gene Attenuates ox-LDL Induced Apoptosis in HASMCs

A Molecular Mechanism of Pyruvate Protection against Cytotoxicity of Reactive Oxygen Species in Osteoblasts

AMPK Potentiates Hypertonicity-Induced Apoptosis by Suppressing NFκB/COX-2 in Medullary Interstitial Cells.